Fig. 1From: Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLETPatient disposition for the SCARLET Study in France. INR, international normalized ratio; WBC, white blood cell. aOne study patient randomized to the placebo group was administered a dose of ART-123 in error; this patient is included in the ART-1 23 group for safety analysesBack to article page